{"id":"NCT03872453","sponsor":"Pfizer","briefTitle":"Acute Treatment Trial in Adult Subjects With Migraines","officialTitle":"Phase II/III: Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial of BHV-3500 for the Acute Treatment of Migraine","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2019-03-25","primaryCompletion":"2019-10-31","completion":"2019-11-11","firstPosted":"2019-03-13","resultsPosted":"2022-10-13","lastUpdate":"2023-09-25"},"enrollment":2154,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Zavegepant","otherNames":["BHV3500"]},{"type":"DRUG","name":"Zavegepant matching placebo","otherNames":[]},{"type":"DEVICE","name":"Intranasal Aptar Pharma Unit Dose System","otherNames":[]}],"arms":[{"label":"Zavegepant 5 mg","type":"EXPERIMENTAL"},{"label":"Zavegepant 10 mg","type":"EXPERIMENTAL"},{"label":"Zavegepant 20 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the safety and efficacy of three different intranasal dose levels of zavegepant (BHV-3500), relative to placebo, in the acute treatment of moderate to severe migraine.","primaryOutcome":{"measure":"Percentage of Participants With Freedom From Pain at 2 Hours Post-dose","timeFrame":"2 hours post-dose","effectByArm":[{"arm":"Zavegepant 5 mg","deltaMin":19.6,"sd":null},{"arm":"Zavegepant 10 mg","deltaMin":22.5,"sd":null},{"arm":"Zavegepant 20 mg","deltaMin":23.1,"sd":null},{"arm":"Placebo","deltaMin":15.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":"0.1214"},{"comp":"OG001 vs OG003","p":"0.0113"},{"comp":"OG002 vs OG003","p":"0.0055"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":82,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=BHV3500-201"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":388},"commonTop":["Dysgeusia","Nasal discomfort"]}}